Michael Panny

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

Christoph Kornauth, Tea Pemovska, Gregory I. Vladimer et al. · Cancer Discovery · 2021 · 196 citations · Full text

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia

Bernd Boidol, Christoph Kornauth, Emiel van der Kouwe et al. · Blood · 2017 · 70 citations

Exposure to Air Ions in Indoor Environments: Experimental Study with Healthy Adults

Peter Wallner, Michael Kundi, Michael Panny et al. · International Journal of Environmental Research and Public Health · 2015 · 24 citations · Full text

High‐dose Bendamustine‐<scp>EAM</scp> followed by autologous stem cell rescue results in long‐term remission rates in lymphoma patients, without renal toxicity

Thomas Noesslinger, Michael Panny, Ralph Simanek et al. · European Journal Of Haematology · 2018 · 16 citations

Angio-Seal Use in Patients with Peripheral Arterial Disease (ASPIRE)

Reinhold Katzenschlager, Reinhold Tischler, G. Kalchhauser et al. · Angiology · 2009 · 15 citations